Facebook Login | Sign Up | Login
A Recent History Of The Pharmaceutical Industry - Based On All Five Forces
August 2007 (The New Business Road Test) ProductionIntellectual PropertyCompetitionMarketsBusiness ModelPorters 5 Forces.
Going Digital: A Sound Guide for Songwriters and Musicians
T-Shirts and Suits: A Guide to the Business of Creativity
Creativebias Helpsheet: Conducting and Using Market Research - Design
Others Also Viewed:
Barriers to Entry
Investor Groups and Angel Communities in Scotland This case study is a recent history of the pharmaceutical industry based on all of Porter 's five forces. If you would like to try this assessment on your own business then try out our Porter 's 5 Forces Assessment
In the 1970s and 1980s, the average profit margin (as a percentage of revenues) of the Fortune 500 pharmaceutical companies was two times greater than the median for all industries in the Fortune 500. Each drug introduced between 1981 and 1983 ‘made at least $36 million more for its investors, after taxes, than was needed to pay off the costs to develop it . . . Such profitability was two to three percentage points greater than for comparable industries, even after factoring in the risks of new drug development’. Nearly two decades later, in 1999, the industry was still a star. The pharmaceutical industry ranked at the top in all three of Fortune magazine’s measures of profitability: return on sales, return on assets and return on equity. What made the global pharmaceutical industry so profitable for so long? Why has its profitability remained so strong, and will the industry remain so attractive?
Threat of entry
For an entrepreneur, high barriers to entry make it more difficult to launch a venture. But